AAAAAA
Results: 1-25/36
Authors:
Ramakrishnan, R
Jusko, WJ
Citation: R. Ramakrishnan et Wj. Jusko, Interactions of aspirin and salicylic acid with prednisolone for inhibition of lymphocyte proliferation, INT IMMUNO, 1(11), 2001, pp. 2035-2042
Authors:
Krzyzanski, W
Jusko, WJ
Citation: W. Krzyzanski et Wj. Jusko, Indirect pharmacodynamic models for responses with multicompartmental distribution or polyexponential disposition, J PHARMA PH, 28(1), 2001, pp. 57-78
Authors:
Gobburu, JVS
Jusko, WJ
Citation: Jvs. Gobburu et Wj. Jusko, Role of dosage regimen in controlling indirect pharmacodynamic responses, ADV DRUG DE, 46(1-3), 2001, pp. 45-57
Authors:
Wyska, E
Jusko, WJ
Citation: E. Wyska et Wj. Jusko, Approaches to pharmacokinetic/pharmacodynamic modeling during pregnancy, SEM PERINAT, 25(3), 2001, pp. 124-132
Authors:
Puchalski, TA
Krzyzanski, W
Blum, RA
Jusko, WJ
Citation: Ta. Puchalski et al., Pharmacodynamic modeling of lansoprazole using an indirect irreversible response model, J CLIN PHAR, 41(3), 2001, pp. 251-258
Authors:
Magee, MH
Blum, RA
Lates, CD
Jusko, WJ
Citation: Mh. Magee et al., Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race, J CLIN PHAR, 41(11), 2001, pp. 1180-1194
Authors:
Meno-Tetang, GML
Blum, RA
Schwartz, KE
Jusko, WJ
Citation: Gml. Meno-tetang et al., Effects of oral prasterone (dehydroepiandrosterone) on single-dose pharmacokinetics of oral prednisone and cortisol suppression in normal women, J CLIN PHAR, 41(11), 2001, pp. 1195-1205
Authors:
Mager, DE
Jusko, WJ
Citation: De. Mager et Wj. Jusko, Pharmacodynamic modeling of time-dependent transduction systems, CLIN PHARM, 70(3), 2001, pp. 210-216
Authors:
Krzyzanski, W
Chakraborty, A
Jusko, WJ
Citation: W. Krzyzanski et al., Algorithm for application of fourier analysis for biorhythmic baselines ofpharmacodynamic indirect response models, CHRONOBIO I, 17(1), 2000, pp. 77-93
Authors:
Gabrielsson, K
Jusko, WJ
Alari, L
Citation: K. Gabrielsson et al., Modeling of dose-response-time data: Four examples of estimating the turnover parameters and generating kinetic functions from response profiles, BIOPHARM DR, 21(2), 2000, pp. 41-52
Authors:
Benincosa, LJ
Chow, FS
Tobia, LP
Kwok, DC
Davis, CB
Jusko, WJ
Citation: Lj. Benincosa et al., Pharmacokinetics and pharmacodynamics of a humanized monoclonal antibody to factor IX in cynomolgus monkeys, J PHARM EXP, 292(2), 2000, pp. 810-816
Authors:
Levy, G
Zamacona, MK
Jusko, WJ
Citation: G. Levy et al., Developing compliance instructions for drug labeling, CLIN PHARM, 68(6), 2000, pp. 586-591
Authors:
Gobburu, JVS
Agerso, H
Jusko, WJ
Ynddal, L
Citation: Jvs. Gobburu et al., Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers, PHARM RES, 16(9), 1999, pp. 1412-1416
Authors:
Fasanmade, AA
Jusko, WJ
Citation: Aa. Fasanmade et Wj. Jusko, Immunodynamics of methylprednisolone induced T-cell trafficking and deactivation using whole blood lymphocyte proliferation techniques in the rat, BIOPHARM DR, 20(5), 1999, pp. 255-261
Authors:
Sharma, A
Jusko, WJ
Fulmor, IE
Norton, J
Uderman, HD
Salazar, DE
Citation: A. Sharma et al., Pharmacokinetics and pharmacodynamics of avitriptan during intravenous administration in healthy subjects, J CLIN PHAR, 39(7), 1999, pp. 685-694
Authors:
Chakraborty, A
Blum, RA
Mis, SM
Cutler, DL
Jusko, WJ
Citation: A. Chakraborty et al., Pharmacokinetic and adrenal interactions of IL-10 and prednisone in healthy volunteers, J CLIN PHAR, 39(6), 1999, pp. 624-635
Authors:
Chow, FS
Sharma, A
Jusko, WJ
Citation: Fs. Chow et al., Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone, J PHAR BIOP, 27(6), 1999, pp. 559-575
Authors:
Krzyzanski, W
Ramakrishnan, R
Jusko, WJ
Citation: W. Krzyzanski et al., Basic pharmacodynamic models for agents that alter production of natural cells, J PHAR BIOP, 27(5), 1999, pp. 467-489
Authors:
Ferron, GM
Pyszczynski, NA
Jusko, WJ
Citation: Gm. Ferron et al., Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in adrenalectomized rats, J PHAR BIOP, 27(1), 1999, pp. 1-21
Authors:
Chakraborty, A
Krzyzanski, W
Jusko, WJ
Citation: A. Chakraborty et al., Mathematical modeling of circadian cortisol concentrations using indirect response models: Comparison of several methods, J PHAR BIOP, 27(1), 1999, pp. 23-43
Authors:
Sun, YN
Lee, HJ
Almon, RR
Jusko, WJ
Citation: Yn. Sun et al., A pharmacokinetic pharmacodynamic model for recombinant human growth hormone effects on induction of insulin-like growth factor I in monkeys, J PHARM EXP, 289(3), 1999, pp. 1523-1532
Authors:
Sun, YN
McKay, LI
DuBois, DC
Jusko, WJ
Almon, RR
Citation: Yn. Sun et al., Pharmacokinetic/pharmacodynamic models for corticosteroid receptor down-regulation and glutamine synthetase induction in rat skeletal muscle by a receptor/gene-mediated mechanism, J PHARM EXP, 288(2), 1999, pp. 720-728
Authors:
Sun, YN
Jusko, WJ
Citation: Yn. Sun et Wj. Jusko, Role of baseline parameters in determining indirect pharmacodynamic responses, J PHARM SCI, 88(10), 1999, pp. 987-990
Authors:
Meno-Tetang, GML
Gobburu, JVS
Jusko, WJ
Citation: Gml. Meno-tetang et al., Influence of gender on prednisolone effects on whole blood T-cell deactivation and trafficking in rats, J PHARM SCI, 88(1), 1999, pp. 46-51
Authors:
Chakraborty, A
Blum, RA
Cutler, DL
Jusko, WJ
Citation: A. Chakraborty et al., Pharmacoimmunodynamic interactions of interleukin-10 and prednisone in healthy volunteers, CLIN PHARM, 65(3), 1999, pp. 304-318